Open Trial of Miglitol in Type 1 Diabetic Patients With Insulin Treatment
Sponsor: Sanwa Kagaku Kenkyusho Co., Ltd.
A PHASE3 clinical study on Type 1 Diabetes Mellitus, this trial is completed. The trial is conducted by Sanwa Kagaku Kenkyusho Co., Ltd. and has accumulated 6 data snapshots since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sanwa Kagaku Kenkyusho Co., Ltd.
For direct contact, visit the study record on ClinicalTrials.gov .